バイオコンジュゲーションの市場規模、シェア、動向分析レポート：製品・サービス別、手法別、生体分子タイプ別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

バイオコンジュゲーション市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、バイオコンジュゲーションの世界市場規模は2030年までに96億7,000万米ドルに達すると予測され、2025年から2030年までのCAGRは9.54％で成長すると予測されています。

バイオコンジュゲーション業界は、標的治療薬に対する需要の高まりと、腫瘍学やその他の治療における抗体薬物複合体（ADC）の採用拡大によって牽引されています。精密医療と部位特異的バイオコンジュゲーション技術の進歩が薬剤の有効性を高め、市場拡大を牽引しています。バイオ医薬品の研究開発投資の増加は、生物製剤、タンパク質コンジュゲーション、核酸ベースの治療法における技術革新を加速させています。

さらに、診断、バイオマテリアル、ドラッグデリバリーシステムへの応用拡大も、特にバイオセンサーやイメージング剤の採用増加とともに成長を後押ししています。バイオコンジュゲーションの受託研究（CRO）や受託製造（CMO）サービスの急増は、市場開拓をさらに後押ししています。さらに、規制当局の支援、戦略的な業界提携、クリックケミストリーやリンカー技術の技術的進歩が、バイオコンジュゲーション業界を前進させる主な要因となっています。

COVID-19パンデミックの間、バイオコンジュゲーション技術の需要は、特にワクチン開発と迅速診断において急増しました。バイオコンジュゲーションは、抗原の安定性と免疫反応を高め、mRNAベースの製剤などのワクチンの有効性を向上させる上で重要な役割を果たしました。さらに、診断アッセイにも広く用いられ、バイオセンサーやイムノアッセイを通じてウイルスをより迅速かつ正確に検出できるようになりました。大量生産が急務であったため、CROやCMOへのアウトソーシングが増加し、研究開発と製造が加速しました。これらの要因により、パンデミック対応とワクチン革新におけるバイオコンジュゲーションの重要な役割が浮き彫りになりました。

さらに、精密医療と生物製剤の進歩がバイオコンジュゲーション技術の需要を押し上げ、標的ドラッグデリバリーと治療効果の向上を可能にしています。抗体薬物複合体（ADC）、タンパク質治療薬、遺伝子治療薬の台頭により、正確な部位特異的コンジュゲーションとリンカー化学の改良の必要性が高まっています。バイオコンジュゲーションは個別化治療においても重要な役割を果たし、より高い特異性と副作用の低減を保証しています。バイオ医薬品の研究開発が拡大するにつれ、医薬品開発、診断、生体材料におけるバイオコンジュゲーション技術の採用は拡大し続け、現代医療の未来を形成しています。

しかし、抗体-薬物複合体（ADC）やペプチド-薬物複合体（PDC）などのバイオコンジュゲート医薬品の開発には、高価な原材料、特殊な装置、複雑な製造工程のために高いコストがかかります。安定で効果的なバイオコンジュゲートを製造するには、高度なリンカー技術、部位特異的コンジュゲーション法、厳格な品質管理が必要であり、これがさらにコストを押し上げます。さらに、高い研究開発費と長い医薬品承認スケジュールは、製薬企業やバイオテクノロジー企業に大きな財務リスクをもたらします。規制上のハードル、大規模な臨床試験、スケーラビリティの課題も重荷となり、バイオコンジュゲーションによる医薬品開発は資本集約的で時間のかかるプロセスとなり、中小企業や新興企業の参入を制限しています。

バイオコンジュゲーション市場レポートハイライト

• 消耗品セグメントは、バイオコンジュゲーションプロセスに不可欠な試薬、リンカー、ラベリングキットの需要が高いことから、2024年には45.45%の最大売上シェアで市場をリードしました。研究開発活動の活発化と抗体薬物複合体（ADC）の採用拡大が、同分野の成長をさらに後押ししました。一方、サービス分野は予測期間中に最も速いCAGRで成長すると予想されます。
• 技術別では、ケミカルコンジュゲーション分野が2024年に最大の市場収益シェアを占めました。その理由は、高い効率性、拡張性、抗体薬物コンジュゲート（ADC）、タンパク質標識、ナノ粒子機能化における広範な使用です。その確立されたプロトコルと様々な生体分子との適合性が、さらにその優位性を後押ししています。一方、クリックケミストリー分野は予測期間中に最も速いCAGRで成長すると予想されています。
• 生体分子タイプ別に見ると、抗体セグメントは、抗体薬物複合体（ADC）、標的治療薬、イムノアッセイにおいて重要な役割を果たすため、2024年に最大の市場収益シェアを占めました。その高い特異性、安定性、腫瘍学、感染症、精密医療における広範な応用が、市場の優位性をさらに高めています。一方、オリゴヌクレオチド分野は予測期間中に最も速いCAGRで成長すると予想されています。
• 用途別では、抗体薬物複合体（ADC）、ペプチド薬物複合体（PDC）、標的ドラッグデリバリーシステムの採用が増加していることから、2024年には治療薬分野が最大の収益シェアを占めました。精密医療、生物学的製剤、がん治療に対する需要の高まりが、同市場の牽引役となっています。一方、診断分野は予測期間中に最も速いCAGRで成長すると予想されます。
• 最終用途に基づくと、研究開発投資の増加、標的治療薬の需要、抗体薬物複合体（ADC）や生物製剤の開発により、製薬・バイオテクノロジー企業分野が2024年に最大の市場収益シェアを占めました。共同研究の増加、バイオコンジュゲーション・サービスのアウトソーシング、精密医療の進展が市場の優位性をさらに後押ししています。一方、CRO &CMOsセグメントは予測期間中最も速いCAGRで成長すると予想されます。
• 北米は、旺盛なバイオ医薬品研究開発投資、抗体薬物複合体（ADC）の高い採用率、高度なヘルスケアインフラが牽引し、2024年の売上高シェア43.75%で市場を独占しました。主要製薬・バイオテクノロジー企業の存在、有利な規制支援、精密医療に対する需要の高まりが、市場の成長をさらに後押ししています。一方、アジア太平洋地域は予測期間中に最も速いCAGRで成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 バイオコンジュゲーション市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• バイオコンジュゲーション市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 バイオコンジュゲーション市場：製品とサービスの推定・動向分析

• 製品・サービスのセグメントダッシュボード
• 世界のバイオコンジュゲーション市場の製品とサービスの変動分析
• 世界のバイオコンジュゲーション市場規模と動向分析（製品・サービス別、2018～2030年）
• 消耗品
  • 試薬とキット
  • ラベル
  • その他の消耗品
• 機器
  • クロマトグラフィーシステム
  • 分光機器
  • 質量分析計
  • フローサイトメーター
  • 電気泳動装置
  • ろ過システム
  • ミキサーとシェーカー
  • インキュベーター
  • その他の機器
• サービス
  • カスタム合成および共役サービス
  • 分析および特性評価サービス
  • スケールアップおよび製造サービス
  • その他のサービス

第5章 バイオコンジュゲーション市場：バイオ分子タイプの推定・動向分析

• バイオ分子タイプのセグメントダッシュボード
• 世界のバイオコンジュゲーション市場のバイオ分子タイプの変動分析
• 世界のバイオコンジュゲーション市場規模と動向分析（バイオ分子タイプ別、2018～2030年）
• 抗体
• タンパク質
• ペプチド
• オリゴヌクレオチド
• その他の生体分子

第6章 バイオコンジュゲーション市場：手法の推定・動向分析

• 手法のセグメントダッシュボード
• 世界のバイオコンジュゲーション市場の手法変動分析
• 世界のバイオコンジュゲーション市場規模と動向分析（手法別、2018～2030年）
• 化学結合
• 酵素媒介結合
• クリックケミストリー
• 光反応性架橋
• その他の手法

第7章 バイオコンジュゲーション市場：用途の推定・動向分析

• 用途のセグメントダッシュボード
• 世界のバイオコンジュゲーション市場の用途変動分析
• 世界のバイオコンジュゲーション市場規模と動向分析（用途別、2018～2030年）
• 治療薬
  • 抗体薬物複合体
  • タンパク質薬物複合体
  • ペプチド-薬物複合体
  • その他の治療用途
• 研究開発
• 診断

第8章 バイオコンジュゲーション市場：最終用途の推定・動向分析

• 最終用途のセグメントダッシュボード
• 世界のバイオコンジュゲーション市場の最終用途変動分析
• 世界のバイオコンジュゲーション市場規模と動向分析（最終用途別、2018～2030年）
• 製薬・バイオテクノロジー企業
• CROとCMO
• 学術調査機関
• 病院、臨床検査室、診断検査室

第9章 バイオコンジュゲーション市場：製品・サービス、バイオ分子タイプ、技術、用途、最終用途別の地域推定・動向分析

• 地域別市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 市場規模と予測動向分析、2018年から2030年まで：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/リスト
  • Danaher
  • Thermo Fisher Scientific Inc.
  • Lonza Group
  • Merck KGaA（MilliporeSigma）
  • Sartorius AG
  • Abbvie, Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Catalent, Inc.
  • BD

List of Tables

• Table 1 List of abbreviation
• Table 2 Global bioconjugation market, by region, 2018 - 2030 (USD Million)
• Table 3 Global bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 4 Global bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 5 Global bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 6 Global bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 7 Global bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 8 North America bioconjugation market, by country, 2018 - 2030 (USD Million)
• Table 9 North America bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 10 North America bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 11 North America bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 12 North America bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 13 North America bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 14 U.S. bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 15 U.S. bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 16 U.S. bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 17 U.S. bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 18 U.S. bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 19 Canada bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 20 Canada bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 21 Canada bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 22 Canada bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 23 Canada bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 24 Mexico bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 25 Mexico bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 26 Mexico bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 27 Mexico bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 28 Mexico bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 29 Europe bioconjugation market, by country, 2018 - 2030 (USD Million)
• Table 30 Europe bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 31 Europe bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 32 Europe bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 33 Europe bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 34 Europe bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 35 Germany bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 36 Germany bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 37 Germany bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 38 Germany bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 39 Germany bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 40 UK bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 41 UK bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 42 UK bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 43 UK bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 44 UK bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 45 France bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 46 France bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 47 France bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 48 France bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 49 France bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 50 Italy bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 51 Italy bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 52 Italy bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 53 Italy bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 54 Italy bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 55 Spain bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 56 Spain bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 57 Spain bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 58 Spain bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 59 Spain bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 60 Denmark bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 61 Denmark bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 62 Denmark bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 63 Denmark bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 64 Denmark bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 65 Sweden bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 66 Sweden bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 67 Sweden bioconjugation market, by technique, 2018 - 2030 (USD Million
• Table 68 Sweden bioconjugation market, by application, 2018 - 2030 (USD Million
• Table 69 Sweden bioconjugation market, by end use, 2018 - 2030 (USD Million
• Table 70 Norway bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 71 Norway bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 72 Norway bioconjugation market, by technique, 2018 - 2030 (USD Million
• Table 73 Norway bioconjugation market, by application, 2018 - 2030 (USD Million
• Table 74 Norway bioconjugation market, by end use, 2018 - 2030 (USD Million
• Table 75 Asia Pacific bioconjugation market, by country, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific bioconjugation market, by technique, 2018 - 2030 (USD Million
• Table 78 Asia Pacific bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific bioconjugation market, by application, 2018 - 2030 (USD Million
• Table 80 Asia Pacific bioconjugation market, by end use, 2018 - 2030 (USD Million
• Table 81 China bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 82 China bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 83 China bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 84 China bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 85 China bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 86 Japan bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 87 Japan bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 88 Japan bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 89 Japan bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 90 Japan bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 91 India bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 92 India bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 93 India bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 94 India bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 95 India bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 96 South Korea bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 97 South Korea bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 98 South Korea bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 99 South Korea bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 100 South Korea bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 101 Australia bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 102 Australia bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 103 Australia bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 104 Australia bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 105 Australia bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 106 Thailand bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 107 Thailand bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 108 Thailand bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 109 Thailand bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 110 Thailand bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 111 Latin America bioconjugation market, by country, 2018 - 2030 (USD Million)
• Table 112 Latin America bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 113 Latin America bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 114 Latin America bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 115 Latin America bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 116 Latin America bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 117 Brazil bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 118 Brazil bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 119 Brazil bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 120 Brazil bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 121 Brazil bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 122 Argentina bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 123 Argentina bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 124 Argentina bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 125 Argentina bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 126 Argentina bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 127 MEA bioconjugation market, by country, 2018 - 2030 (USD Million)
• Table 128 MEA bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 129 MEA bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 130 MEA bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 131 MEA bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 132 MEA bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 133 South Africa bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 134 South Africa bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 135 South Africa bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 136 South Africa bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 137 South Africa bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 138 Saudi Arabia bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 143 UAE bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 144 UAE bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 145 UAE bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 146 UAE bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 147 UAE bioconjugation market, by end use, 2018 - 2030 (USD Million)
• Table 148 Kuwait bioconjugation market, by product & services, 2018 - 2030 (USD Million)
• Table 149 Kuwait bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
• Table 150 Kuwait bioconjugation market, by technique, 2018 - 2030 (USD Million)
• Table 151 Kuwait bioconjugation market, by application, 2018 - 2030 (USD Million)
• Table 152 Kuwait bioconjugation market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Bioconjugation market: Market outlook
• Fig. 5 Bioconjugation market: Segment outlook
• Fig. 6 Bioconjugation market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Bioconjugation market driver impact
• Fig. 9 Bioconjugation market restraint impact
• Fig. 10 Bioconjugation market: Product & services outlook and key takeaways
• Fig. 11 Bioconjugation market: Product & services movement analysis
• Fig. 12 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Linker & crosslinking reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Labeling reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Modification reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Other reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Labels market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Fluorescent tags market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Haptens market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Polymers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Bead coupling market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Other labels market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Other consumables market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Chromatography systems market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Spectroscopy instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Mass spectrometers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Flow cytometers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Electrophoresis equipment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Filtration systems market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Mixers & shakers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Incubators market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Other instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Custom synthesis & conjugation services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Analytical & characterization services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Scale-up & manufacturing services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Other services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Bioconjugation market: Biomolecule type outlook and key takeaways
• Fig. 42 Bioconjugation market: Biomolecule type movement analysis
• Fig. 43 Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Proteins market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Peptides market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Oligonucleotides market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Other biomolecules market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Bioconjugation market: Technique outlook and key takeaways
• Fig. 49 Bioconjugation market: Technique movement analysis
• Fig. 50 Chemical conjugation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Enzyme-mediated conjugation market estimates and forecast, 2018 - 2030 (USD Million
• Fig. 52 Click chemistry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Photoreactive crosslinking market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Other techniques market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Bioconjugation market: Application outlook and key takeaways
• Fig. 56 Bioconjugation market: Application movement analysis
• Fig. 57 Therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Antibody-drug conjugates market estimates and forecast, 2018 - 2030 (USD Million
• Fig. 59 Protein-drug conjugates market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Peptide-drug conjugates market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Other therapeutic applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Research & Development market estimates and forecast, 2018 - 2030 (USD Million
• Fig. 63 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Bioconjugation market: End use outlook and key takeaways
• Fig. 65 Bioconjugation market: End use movement analysis
• Fig. 66 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 CROs & CMOs market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 68 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 69 Hospitals, clinical, & diagnostic laboratories market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 70 Global bioconjugation market: Regional outlook and key takeaways
• Fig. 71 Global bioconjugation market: Regional movement analysis
• Fig. 72 North America bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 US bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Canada bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Mexico bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Europe bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 UK bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Germany bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 France bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Italy bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Spain bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Denmark bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Sweden bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Norway bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Asia Pacific bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 China bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Japan bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 India bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Thailand bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 South Korea bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Australia bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Latin America bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 93 Brazil bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Argentina bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Middle East and Africa bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 South Africa bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Saudi Arabia bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 UAE bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 99 Kuwait bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)

Bioconjugation Market Growth & Trends:

The global bioconjugation market size is anticipated to reach USD 9.67 billion by 2030 and is projected to grow at a CAGR of 9.54% from 2025 to 2030, according to a new report by Grand View Research, Inc. The bioconjugation industry is driven by rising demand for targeted therapeutics and the growing adoption of antibody-drug conjugates (ADCs) in oncology and other treatments. Advancements in precision medicine and site-specific bioconjugation techniques are enhancing drug efficacy driving market expansion. Increasing biopharmaceutical R&D investments are accelerating innovation in biologics, protein conjugation, and nucleic acid-based therapies.

In addition, expanding applications in diagnostics, biomaterials, and drug delivery systems are also fueling growth, particularly with the rising adoption of biosensors and imaging agents. The surge in contract research (CROs) and contract manufacturing (CMOs) services for bioconjugation is further boosting market development. In addition, regulatory support, strategic industry collaborations, and technological advancements in click chemistry and linker technologies are key factors propelling the bioconjugation industry forward.

During the COVID-19 pandemic, the demand for bioconjugation technologies surged, particularly in vaccine development and rapid diagnostics. Bioconjugation played a crucial role in enhancing antigen stability and immune response, improving the efficacy of vaccines such as mRNA-based formulations. In addition, it was widely used in diagnostic assays, enabling faster and more accurate detection of the virus through biosensors and immunoassays. The urgent need for large-scale production led to increased outsourcing to CROs and CMOs, accelerating R&D and manufacturing. These factors underscored the critical role of bioconjugation in pandemic response and vaccine innovation.

Moreover, advancements in precision medicine and biologics are driving the demand for bioconjugation technologies, enabling targeted drug delivery and enhanced therapeutic efficacy. The rise of antibody-drug conjugates (ADCs), protein therapeutics, and gene therapies has increased the need for precise site-specific conjugation and improved linker chemistry. Bioconjugation also plays a key role in personalized treatments, ensuring higher specificity and reduced side effects. As biopharmaceutical R&D expands, the adoption of bioconjugation techniques in drug development, diagnostics, and biomaterials continues to grow, shaping the future of modern medicine.

However, the development of bioconjugated drugs, such as antibody-drug conjugates (ADCs) and peptide-drug conjugates (PDCs), involves high costs due to expensive raw materials, specialized equipment, and complex manufacturing processes. Producing stable and effective bioconjugates requires advanced linker technologies, site-specific conjugation methods, and stringent quality control, further driving up costs. In addition, high R&D expenses and long drug approval timelines pose significant financial risks for pharmaceutical and biotechnology companies. Regulatory hurdles, extensive clinical trials, and scalability challenges add to the burden, making bioconjugation drug development a capital-intensive and time-consuming process, limiting entry for smaller firms and startups.

Bioconjugation Market Report Highlights:

• The consumables segment led the market with the largest revenue share of 45.45% in 2024, due to the high demand for reagents, linkers, and labeling kits essential for bioconjugation processes. Increasing R&D activities and the growing adoption of antibody-drug conjugates (ADCs) further fueled segment growth. On the other hand, the services segment is expected to grow at the fastest CAGR over the forecast period.
• Based on technique, the chemical conjugation segment accounted for the largest market revenue share in 2024, due to its high efficiency, scalability, and widespread use in antibody-drug conjugates (ADCs), protein labeling, and nanoparticle functionalization. Its well-established protocols and compatibility with various biomolecules further drove its dominance. On the other hand, the click chemistry segment is expected to grow at the fastest CAGR over the forecast period.
• Based on biomolecule type, the antibodies segment accounted for the largest market revenue share in 2024, due to their crucial role in antibody-drug conjugates (ADCs), targeted therapeutics, and immunoassays. Their high specificity, stability, and widespread application in oncology, infectious diseases, and precision medicine further drive market dominance. On the other hand, the oligonucleotides segment is expected to grow at the fastest CAGR over the forecast period.
• Based on application, the therapeutics segment accounted for the largest revenue share in 2024, due to the rising adoption of antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), and targeted drug delivery systems. Increasing demand for precision medicine, biologics, and cancer therapies further drives its market leadership. On the other hand, the diagnostics segment is expected to grow at the fastest CAGR over the forecast period.
• Based on end use, the pharmaceutical & biotechnological companies segment accounted for the largest market revenue share in 2024, due to increasing R&D investments, demand for targeted therapeutics, and the development of antibody-drug conjugates (ADCs) and biologics. Growing collaborations, outsourcing of bioconjugation services, and advancements in precision medicine further fueled market dominance. On the other hand, the CROs & CMOs segment is expected to grow at the fastest CAGR over the forecast period.
• The North America dominated the market with the largest revenue share of 43.75% in 2024, driven by strong biopharmaceutical R&D investments, high adoption of antibody-drug conjugates (ADCs), and advanced healthcare infrastructure. The presence of leading pharmaceutical & biotechnology companies, favorable regulatory support, and growing demand for precision medicine further fueled market growth. On the other hand, the Asia Pacific region is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Services
  • 1.2.2. Biomolecule Type
  • 1.2.3. Technique
  • 1.2.4. Application
  • 1.2.5. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Bioconjugation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising demand for targeted drug delivery
    • 3.2.1.2. Technological innovations in linker chemistry
    • 3.2.1.3. Growing applications in diagnostics
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High development costs
    • 3.2.2.2. Short shelf life of bioconjugated products
    • 3.2.2.3. Alternative drug delivery technologies
• 3.3. Bioconjugation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bioconjugation Market: Product & Services Estimates & Trend Analysis

• 4.1. Product & Services Segment Dashboard
• 4.2. Global Bioconjugation Market Product & Services Movement Analysis
• 4.3. Global Bioconjugation Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Million)
• 4.4. Consumables
  • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. Reagents & Kits
    • 4.4.2.1. Reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.2. Linker & Crosslinking Reagents & Kits
      • 4.4.2.2.1. Linker & crosslinking reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.3. Labeling Reagents & Kits
      • 4.4.2.3.1. Labeling reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.4. Modification Reagents & Kits
      • 4.4.2.4.1. Modification reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.5. Other Reagents & Kits
      • 4.4.2.5.1. Other reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Labels
    • 4.4.3.1. Labels market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.2. Fluorescent Tags
      • 4.4.3.2.1. Fluorescent tags market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.3. Enzymes
      • 4.4.3.3.1. Enzymes market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.4. Haptens
      • 4.4.3.4.1. Haptens market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.5. Polymers
      • 4.4.3.5.1. Polymers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.6. Bead Coupling
      • 4.4.3.6.1. Bead coupling market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.7. Other Labels
      • 4.4.3.7.1. Other labels market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.4. Other Consumables
    • 4.4.4.1. Other consumables market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Instruments
  • 4.5.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.2. Chromatography Systems
    • 4.5.2.1. Chromatography systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.3. Spectroscopy Instruments
    • 4.5.3.1. Spectroscopy instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.4. Mass Spectrometers
    • 4.5.4.1. Mass spectrometers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.5. Flow Cytometers
    • 4.5.5.1. Flow cytometers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.6. Electrophoresis Equipment
    • 4.5.6.1. Electrophoresis equipment market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.7. Filtration Systems
    • 4.5.7.1. Filtration systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.8. Mixers & Shakers
    • 4.5.8.1. Mixers & shakers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.9. Incubators
    • 4.5.9.1. Incubators market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.10. Other Instruments
    • 4.5.10.1. Other instruments market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6.2. Custom Synthesis & Conjugation Services
    • 4.6.2.1. Custom synthesis & conjugation services market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6.3. Analytical & Characterization Services
    • 4.6.3.1. Analytical & characterization services market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6.4. Scale-up & Manufacturing Services
    • 4.6.4.1. Scale-up & manufacturing services market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6.5. Other Services
    • 4.6.5.1. Other services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Bioconjugation Market: Biomolecule Type Estimates & Trend Analysis

• 5.1. Biomolecule Type Segment Dashboard
• 5.2. Global Bioconjugation Market Biomolecule Type Movement Analysis
• 5.3. Global Bioconjugation Market Size & Trend Analysis, by Biomolecule Type, 2018 to 2030 (USD Million)
• 5.4. Antibodies
  • 5.4.1. Antibodies market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Proteins
  • 5.5.1. Proteins market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Peptides
  • 5.6.1. Peptides market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Oligonucleotides
  • 5.7.1. Oligonucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.8. Other Biomolecules
  • 5.8.1. Other biomolecules market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Bioconjugation Market: Technique Estimates & Trend Analysis

• 6.1. Technique Segment Dashboard
• 6.2. Global Bioconjugation Market Technique Movement Analysis
• 6.3. Global Bioconjugation Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
• 6.4. Chemical Conjugation
  • 6.4.1. Chemical conjugation market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Enzyme-Mediated Conjugation
  • 6.5.1. Enzyme-mediated conjugation market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Click Chemistry
  • 6.6.1. Click chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Photoreactive Crosslinking
  • 6.7.1. Photoreactive crosslinking market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.8. Other Techniques
  • 6.8.1. Other techniques market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Bioconjugation Market: Application Estimates & Trend Analysis

• 7.1. Application Segment Dashboard
• 7.2. Global Bioconjugation Market Application Movement Analysis
• 7.3. Global Bioconjugation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 7.4. Therapeutics
  • 7.4.1. Therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.2. Antibody-drug Conjugates
    • 7.4.2.1. Antibody-drug conjugates market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.3. Protein-drug Conjugates
    • 7.4.3.1. Protein-drug conjugates market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.4. Peptide-drug Conjugates
    • 7.4.4.1. Peptide-drug conjugates market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.5. Other Therapeutic Applications
    • 7.4.5.1. Other therapeutic applications market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Research & Development
  • 7.5.1. Research & development market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Diagnostics
  • 7.6.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Bioconjugation Market: End Use Estimates & Trend Analysis

• 8.1. End Use Segment Dashboard
• 8.2. Global Bioconjugation Market End Use Movement Analysis
• 8.3. Global Bioconjugation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 8.4. Pharmaceutical & Biotechnology Companies
  • 8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.5. CROs & CMOs
  • 8.5.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.6. Academic & Research Institutes
  • 8.6.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.7. Hospitals, Clinical, & Diagnostic Laboratories
  • 8.7.1. Hospitals, clinical, & diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Bioconjugation Market: Regional Estimates & Trend Analysis by Product & Services, Biomolecule Type, Technique, Application, and End Use

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 9.4. North America
  • 9.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.7. Norway
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Regulatory framework
    • 9.5.7.3. Competitive scenario
    • 9.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key country dynamics
    • 9.5.8.2. Regulatory framework
    • 9.5.8.3. Competitive scenario
    • 9.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.9. Denmark
    • 9.5.9.1. Key country dynamics
    • 9.5.9.2. Regulatory framework
    • 9.5.9.3. Competitive scenario
    • 9.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.8. MEA
  • 9.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Regulatory framework
    • 9.8.3.3. Competitive scenario
    • 9.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key country dynamics
    • 9.8.4.2. Regulatory framework
    • 9.8.4.3. Competitive scenario
    • 9.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key country dynamics
    • 9.8.5.2. Regulatory framework
    • 9.8.5.3. Competitive scenario
    • 9.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2024
• 10.4. Company Profiles/Listing
  • 10.4.1. Danaher
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Thermo Fisher Scientific Inc.
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Lonza Group
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Merck KGaA (MilliporeSigma)
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Sartorius AG
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Abbvie, Inc.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Bio-Rad Laboratories, Inc.
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Agilent Technologies, Inc.
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Catalent, Inc.
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. BD
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives